Trademarkia Logo

Australia

AU$
WELGEMDA
Accepted: In opposition period

Last updated on 2 Oct 2024

Owner Info

Bridgebio Pharma, Inc.

3160 Porter Dr., Suite 250

Palo Alto CA 94304, UNITED STATES OF AMERICA

Serial Number

2454177 filed on 18 Mar 2024

Correspondent

Jessica L. Rothstein Goodwin Procter LLP

620 Eighth Avenue,

New York NY 10018,

UNITED STATES OF AMERICA

WELGEMDA

Classification Information


Class [005]
Pharmaceuticals for use in the treatment of oncological, cardiological, dermatological, neurological, genetic, orthopedic and metabolic diseases and d Read More

Mark Details


Serial Number

2454177

Registered On

NA

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

23 Feb 2024

Mark Type

US

Legal History


Show more

Status DateAction Taken
2th Oct 2024International Registration in Australia Protected correspondence sent
1st Oct 2024IP Right Registration Published
1st Oct 2024Status change to Registered/Protected
24th Jul 2024Application Accepted correspondence sent
24th Jul 2024IP Right has been Examined
24th Jul 2024IP Right Acceptance Published
3rd Jun 2024Status change to Accepted
30th May 2024Examination expedited
30th May 2024Awaiting examination
30th May 2024IP Right Filed Published